TECHNO MEDICA CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,828 JPY | +2.70% |
|
+1.61% | -17.36% |
| Sales 2022 | 9.7B 61.67M | Sales 2023 | 9.37B 59.56M | Capitalization | 15.97B 102M |
|---|---|---|---|---|---|
| Net income 2022 | 1.28B 8.14M | Net income 2023 | 1.15B 7.31M | EV / Sales 2022 | 0.18 x |
| Net cash position 2022 | 11.52B 73.26M | Net cash position 2023 | 11.75B 74.71M | EV / Sales 2023 | 0.45 x |
| P/E ratio 2022 |
10.4
x | P/E ratio 2023 |
13.9
x | Employees | 225 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 52.21% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.70% | ||
| 1 week | +1.61% | ||
| Current month | +2.70% | ||
| 1 month | +6.22% | ||
| 3 months | +4.34% | ||
| 6 months | -23.83% | ||
| Current year | -17.36% |
1 week
1 751.00
1 857.00
1 month
1 708.001 857.00
Current year
1 687.002 235.00
1 year
1 687.002 625.00
3 years
1 491.002 625.00
5 years
1 449.002 625.00
10 years
1 391.003 370.00
| Managers | Title | Age | Since |
|---|---|---|---|
| President | 51 | 99-05-31 | |
Yasushi Nakano
CTO | Chief Tech/Sci/R&D Officer | 55 | 04-04-30 |
Kazuto Tsugawa
ADM | Chief Administrative Officer | 72 | 17-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| President | 51 | 99-05-31 | |
Masato Takeda
BRD | Director/Board Member | 62 | 97-02-28 |
Kazuto Tsugawa
ADM | Chief Administrative Officer | 72 | 17-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 32 M€ | +17.05% | ||
| 0.00% | 140,441 M€ | +19.40% | ||
| 0.00% | 63,295 M€ | +19.48% | - | |
| 0.00% | 20,360 M€ | +18.26% | - | |
| 0.00% | 17 M€ | +14.54% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-02 | 1,828 | +2.70% | 8 200 |
| 24-05-31 | 1,780 | +0.62% | 6,400 |
| 24-05-30 | 1,769 | +0.63% | 5,500 |
| 24-05-29 | 1,758 | -1.73% | 3,000 |
| 24-05-28 | 1,789 | -0.56% | 5,000 |
Delayed Quote Japan Exchange, June 02, 2024 at 10:27 pm EDT
More quotes
Techno Medica Co., Ltd. is a Japan-based company mainly engaged in development, manufacture, sale and export of analysis device for clinical examination equipment and other medical equipment, as well as devices repair services. The blood collection tube preparation apparatus business provides blood collection peripheral equipment, such as blood and urine collection automation reception equipment, among others, as well as blood tube preparation systems. The laboratory test apparatus business provides blood gas analysis apparatus, electrolyte analyzers, erythrocyte sedimetation rate measuring machines, among others. The consumable goods business provides blood collecting tubes, labels, sensor cards, calibration packs, among others, as well as maintenance services.
Calendar
2024-11-05
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -17.36% | 78.32M | |
| -7.16% | 178B | |
| -1.23% | 107B | |
| -4.86% | 67.04B | |
| -4.28% | 47.23B | |
| +10.32% | 44.62B | |
| +9.28% | 42.5B | |
| +15.10% | 25.22B | |
| -5.88% | 24.14B | |
| -5.38% | 23.69B |
- Stock Market
- Equities
- 6678 Stock
